Basol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Basol

Property Description
Active ingredient Clobetasol propionate
Form Cream, Ointment, Gel, Solution, Foam, or Lotion
Pharmacological class Corticosteroid (Super-High Potency Topical Glucocorticoid)
General purpose Alleviation of severe inflammatory and pruritic skin manifestations
Origin Synthetic fluorinated derivative of prednisolone

What Type of Drug is Basol and What is its Class?

Basol is a prescription-only medication defined by its active ingredient, Clobetasol propionate, and belongs to the powerful corticosteroid pharmacological class. Clobetasol propionate is categorized as a super-high potency topical steroid, a classification reflecting its strength relative to other topical agents. This high-potency nature is clinically recognized for its rapid effect in severe inflammatory cases.

The active substance, Clobetasol propionate, is a synthetic fluorinated glucocorticoid derived chemically from prednisolone, confirming it is a laboratory-created compound. The specific chemical structure significantly boosts its biological activity and ability to penetrate the skin. Basol is a single-ingredient product, positioning it as a dedicated, high-impact topical therapy.


What is Basol’s Composition and Available Form?

The fundamental composition of Basol features Clobetasol propionate as the exclusive active ingredient, prepared for topical administration to the skin. Basol is made available in several dosage forms, including a cream, ointment, gel, lotion, foam, and solution.

This variety of forms is essential because the accompanying inert base/vehicle influences how the active ingredient is delivered to the skin. For example, the ointment form may be used for very dry, chronic lesions requiring maximum occlusion, while a solution or foam provides a clean application method suitable for the scalp or other hairy areas.


What is the General Purpose of This Highly Potent Medication?

The general purpose of Basol is to quickly and substantially control the most severe symptoms of skin inflammation by leveraging its powerful anti-inflammatory properties. Its high potency allows it to provide rapid and effective relief from intense redness, swelling, and debilitating itching (pruritus). A typical neutral use scenario would involve treating the acute flare-up of a chronic condition.

Basol's primary function is to calm the body's overactive inflammatory response through a comprehensive mechanism that includes vasoconstriction (narrowing local blood vessels) at the application site. The overall benefit is the rapid stabilization of acute, symptomatic inflammatory and pruritic manifestations categorized by dermatologists as corticosteroid-responsive dermatoses.

Regulatory References

  1. NIH MedlinePlus on Clobetasol

What side effects are possible with Basol?

Possible Side Effects and Safety Information

Basol, containing the super-high potency topical corticosteroid clobetasol propionate, has an official safety profile structured around both localized skin reactions and the potential for systemic effects due to absorption. All safety information is based on government regulatory documentation, such as FDA and EMA labels.


Local and Dermatological Adverse Reactions

Adverse reactions that occur at the application site are frequently documented. The most common effects reported include a burning and/or stinging sensation. Other common reactions listed in regulatory documents include pruritus (itching), irritation, erythema (redness), folliculitis, skin atrophy (thinning), and telangiectasia.

Frequency Classification Officially Listed Reactions (Examples)
Most Common Burning, stinging sensation
Common Pruritus, skin atrophy, telangiectasia, irritation
Very Rare Hypopigmentation, acneiform eruptions, striae

Systemic Safety and Constraints

Systemic absorption may lead to serious adverse reactions related to the Endocrine System. The most clinically significant systemic risk is Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, which, in severe cases, may result in manifestations of Cushing’s syndrome. The risk of these systemic effects is officially documented to increase with prolonged periods of application and the use of occlusive dressings.

Specific regulatory constraints exist: Basol is not recommended for use in the treatment of rosacea or perioral dermatitis. Due to the high risk of local adverse reactions, the official label advises that it should not be applied to the face, groin, or axillae (armpits). Pediatric patients are identified as a vulnerable population due to their increased susceptibility to systemic toxicity, including linear growth retardation, as noted in official safety information.

Overdose and Emergency Response

Excessive or prolonged use of Basol, a super-high potency topical corticosteroid, can lead to overdose through increased systemic absorption. The core documented manifestation of systemic toxicity is Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, which is officially classified as the primary risk. Overdose may present with documented signs of hypercorticism, such as Cushing’s syndrome, or physiological findings like hyperglycemia and glucosuria.

Seek immediate medical attention upon any suspicion of overdose, excessive use, or if signs of systemic effects are observed. Regulatory agencies advise contacting a Poison Control Center for guidance. The officially described management protocol is symptomatic and supportive treatment, as official labeling states that no specific antidote is known. Medical professionals may conduct tests, such as the ACTH stimulation test, to monitor HPA axis status. A confirmed suppression often requires the drug to be withdrawn gradually under supervision to prevent the severe outcome of adrenal insufficiency. Furthermore, pediatric patients are officially documented as being more susceptible to systemic toxicity due to a higher body surface area to body weight ratio.

Therapeutic Uses of Basol

What Basol Treats: Main Uses and Benefits

Basol is a super-high potency topical corticosteroid generally relevant for easing symptoms related to inflammatory or irritative states where short-term symptomatic assistance is needed. It is commonly used across conditions presenting with acute episodes and significant symptomatic burden.


Key Therapeutic Focus

The medication is used primarily for the management of severe corticosteroid-responsive dermatoses. This includes conditions characterized by periods of heightened symptoms, such as plaque psoriasis (moderate-to-severe forms), intense atopic dermatitis, lichen planus, and discoid lupus erythematosus. This medication is generally reserved for pronounced manifestations and contributes to easing the overall symptom load associated with these chronic skin diseases.

Basol is used for managing symptom clusters that may become intense or disruptive, such as severe pruritus (itching), pronounced redness, and swelling. Applied during phases of increased distress or discomfort, the medication provides supportive relief when symptoms interfere with routine activities. It is also considered relevant for localized lesions that are challenging to treat, assisting with issues like the severe scaling and thickening of chronic plaques. It is relevant for easing severe, persistent itching (pruritus), and may assist with maintaining functional stability during difficult episodes.


Symptom Support: Persistent Itching

Basol is relevant for easing severe, persistent itching (pruritus), and may assist with maintaining functional stability during difficult episodes of inflammatory dermatoses.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Basol?

The population eligibility for Basol (Clobetasol propionate) is strictly controlled by regulatory authorities due to its super-high potency, with rules defining who must not use the medicine and who requires restricted use.

Absolute Contraindications

Basol is contraindicated and must not be used in specific groups, including patients with a known hypersensitivity to clobetasol propionate or any component of the formulation. Use is also prohibited in patients presenting with certain primary skin conditions, such as rosacea, perioral dermatitis, acne vulgaris, or primary untreated infections (bacterial, viral, fungal, parasitic) of the skin or scalp.


Age and Condition Restrictions

Population Group Eligibility Status (Regulatory)
Infants and Children < 12 Years Not recommended or contraindicated due to increased risk of systemic toxicity and HPA axis suppression.
Pregnancy Use is limited to situations where the potential benefit justifies the potential risk to the fetus (FDA Category C).
High-Risk Body Areas Must not be applied to the face, groin, axillae, or used with occlusive dressings unless specified by a healthcare professional.
Hepatic/Renal Impairment Caution is advised due to the potential for delayed drug elimination if significant systemic absorption occurs.

Eligibility is typically established for adults 18 years and older and for adolescents ge 12 years for specific labeled formulations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Basol (Clobetasol propionate) interaction patterns are officially documented by regulatory authorities, focusing on metabolic clearance and known glucocorticoid class effects. The profile is primarily structured around pharmacokinetic and pharmacodynamic interactions.

Pharmacokinetic Interaction: Altered Metabolism

Co-administration with strong CYP3A4 inhibitors may reduce the metabolism of Clobetasol propionate. Regulatory summaries note that this pharmacokinetic interaction results in increased systemic exposure of Basol. Substances such as Ritonavir and Itraconazole are cited as examples of potent CYP3A4 inhibitors that interact with corticosteroids.

Pharmacodynamic Interactions: Additive Effects

Interactions stemming from the drug's glucocorticoid activity are also documented:

  • Antidiabetic Agents: Co-administration may enhance the potential for hyperglycemia (high blood sugar) due to the physiological effects of the corticosteroid.
  • Thiazide or Loop Diuretics: Co-administration may increase the documented risk of hypokalemia (low potassium levels) through additive effects.

No mandatory timing separation rules are documented for the topical formulations (cream, ointment, etc.). Similarly, no specific interactions with food, alcohol, or common herbal products are explicitly stated in the official regulatory prescribing information.

Mechanism of Action

How Basol Works: Pharmacodynamic Mechanism

Basol (Clobetasol propionate) functions by modulating core processes within the skin's cells and local blood vessels. Its action is concentrated in three primary mechanistic domains that collectively suppress the molecular and cellular events of the inflammatory cascade.


Intracellular Receptor Activation and Anti-inflammatory Gene Expression

Basol initiates its mechanism, which exhibits high binding affinity for the Glucocorticoid Receptor (GR) inside skin cells. This binding and activation lead to fundamental changes in the cell's genetic expression. This results in the rapid suppression of genes that produce pro-inflammatory signaling molecules (like cytokines) and the enhanced production of anti-inflammatory proteins, which modulates the balance of gene expression toward an anti-inflammatory profile.


Blockade of the Arachidonic Acid Inflammatory Cascade

A key downstream consequence of receptor activation is the induced synthesis of the protein Lipocortin-1. This protein inhibits the Phospholipase A2 (PLA2) enzyme, effectively blocking the release of Arachidonic Acid—the precursor for key pro-inflammatory agents like prostaglandins and leukotrienes. This comprehensive cascade blockade results in the containment of excessive mediator activity, which are central components of the amplified local physiological response.


Modulation of Local Vascular Tone and Permeability

The drug also engages mechanisms that induce direct, pronounced vasoconstriction of the small blood vessels at the site of application. This physical narrowing of vessels and reduction in capillary permeability reduces the leakage of fluid and immune cells into the tissue. This rapid physiological adjustment contributes to the containment of the local cellular response and is integral to its classification as a high-potency agent.

Dosage and Administration Information

How to Use Basol: Official Administration Guidelines

Basol (Clobetasol propionate 0.05%) is a super-high potency topical corticosteroid prescribed for short-term use, governed by strict application standards.


Administration Scope

Entity Instruction
Route of administration Topical application to the skin only. Use is explicitly restricted from oral, ophthalmic, or intravaginal routes.
Dosing schedule Apply a thin layer to the affected areas. The total applied amount must not exceed 50 grams (or 50 mL) per week for any formulation.
Frequency and timing Application is generally twice daily (morning and evening). Treatment is typically limited to a maximum of 2 consecutive weeks.
Age-group administration rules The preparation is not recommended for use in children under 12 years for cream, gel, or ointment forms, with some liquid formulations restricted to patients under 18 years.

Procedural Constraints and Duration

The treatment protocol for Basol is highly time-constrained and application-specific. Official instructions mandate that the product be rubbed in gently and completely to the skin. The use of occlusive dressings (e.g., airtight bandages) over the treated area is generally prohibited as a matter of administration. Additionally, application must be avoided on sensitive areas including the face, groin, and axillae. The entire protocol is structured to standardize the amount and duration of exposure, ensuring treatment discontinues when symptom control is achieved, even if the maximum duration has not been reached.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Mechanism of Action

Studies explored the drug’s potential influence on nerve signals associated with chronic pain. Research included an examination of specific receptor sites relevant to the drug’s intended pathway.

Key Clinical Trials

Phase 3: Primary Clinical Study

The Phase 3 trial was conducted to evaluate the primary clinical outcome measures of the drug. The study included 450 adult participants diagnosed with refractory neuropathic pain. The primary study group reported changes in their symptoms during the trial period.

  • Reported Outcomes: Findings reported a change in patient outcome measures in 75% of participants over the 12-week study duration. This change was based on a 30% or greater reduction in the patient-reported pain scale score.
  • Adverse Events: Adverse events reported in the study were documented as minimal.

Secondary Study: Combination Therapy

Studies examined whether combination with drug Z showed an association with changes in patient-reported pain scores, alongside changes in inflammatory markers. This secondary trial involved 150 participants and focused on the safety and tolerability of the combination over a six-month period.

  • Observation: The highest reported patient-reported outcomes were observed when participants strictly followed the diet plan specified in the study.

Safety and Exclusion Criteria

Research has noted that participants with pre-existing heart conditions were excluded from the study population. The rationale for this exclusion related to specific observations made in pre-clinical models. No interaction was noted with specific antidepressants listed in the study protocol.

Key Studies & References

  1. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia
  2. A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain
  3. The Prevalence of Pain in Chronic Diseases: An Umbrella Review of Systematic Reviews

Frequently Asked Questions (FAQ)

Common questions about Basol (FAQ)

Q: What are the different conditions or types of skin disorders Basol is typically used for?

A: According to official regulatory documents, Basol is indicated for the temporary relief of the inflammatory and itchy symptoms associated with certain corticosteroid-responsive dermatoses. This includes conditions such as moderate to severe plaque-type psoriasis.


Q: Is Basol considered an antibiotic, antifungal, or another type of treatment?

A: Basol is officially classified as a super-high potency topical corticosteroid. It is a medication designed primarily to suppress inflammation and is not categorized as an antibiotic or an antifungal agent.


Q: How quickly can one expect to see an improvement after starting to use Basol?

A: Regulatory guidance suggests that if no improvement is observed within two weeks of starting treatment, a reassessment of the condition or diagnosis may be necessary. This timeframe is used in regulatory guidance to assess whether treatment should be reevaluated.


Q: Is Basol a treatment that fixes the underlying cause of the condition, or does it only manage symptoms?

A: Basol is used for the relief of the symptoms of skin disorders, specifically the inflammation and itching. Its mechanism of action involves suppressing the body’s inflammatory response, meaning it manages the manifestations rather than curing the underlying cause.


Q: What happens if a person accidentally uses more Basol than the recommended amount?

A: Using amounts greater than what is recommended, or using the product for a longer duration than prescribed, increases the risk of systemic side effects. This includes the potential for suppressing the HPA axis (the system that regulates certain hormones), which may be associated with clinically significant health effects.


Q: Are there certain types of food or drinks that should be avoided while using Basol?

A: Official regulatory prescribing information does not explicitly list any specific interactions with foods, alcohol, or common herbal products that must be avoided while using Basol.


Q: Is it safe to use Basol during pregnancy or while breastfeeding?

A: Regulatory documents state that use during pregnancy is limited to situations where the potential benefit is determined to outweigh the potential risk. For breastfeeding, it is not currently known if applying Basol topically results in enough systemic absorption for the drug to be detectable in human milk.


Q: Why is Basol sometimes mentioned in the context of electrolyte balance, if it's for skin issues?

A: As a corticosteroid, Basol can be absorbed through the skin, leading to systemic effects. Because of its drug class, it may increase the risk of low potassium levels (hypokalemia) when used alongside certain diuretics, which is why it is discussed in relation to electrolyte balance.


Q: Can Basol be used on broken or severely damaged skin?

A: If concomitant skin infections are present or develop, the need for an appropriate antimicrobial agent should be evaluated, and discontinuation of the steroid may be necessary if the infection is not promptly controlled. Use should also be avoided on skin that has already thinned (skin atrophy).


Q: How long does a bottle of Basol typically last for a common treatment duration?

A: Official regulatory guidelines limit the total amount applied to no more than 50 grams or 50 mL per week, and treatment is generally limited to two consecutive weeks. The actual lifespan of a bottle depends on its size and the exact area being treated.


Q: Is it possible for Basol to cause dry skin over time?

A: Official regulatory documents list dryness or dry skin as an adverse reaction that has been reported at the application site.


Q: Can Basol be used on the scalp for scalp-related skin disorders?

A: Yes, specific formulations of the active ingredient in Basol, such as solutions, foams, or shampoos, are designed and indicated for the topical treatment of certain skin conditions that occur on the scalp.


Q: If Basol is for external use, why are potential internal interactions (like with Digoxin) sometimes mentioned?

A: Despite being applied externally, Basol is a highly potent corticosteroid that can be absorbed through the skin into the bloodstream, leading to systemic effects. Because of this, its use can affect internal bodily systems, making potential interactions with certain internal medications a safety consideration.


Q: Does Basol stain clothing or bedding upon application?

A: The official label does not specifically address staining, but as a topical product, it may leave a residue. Labeling suggests the product be rubbed in gently and completely after application.


Q: What are the long-term effects of using Basol for several months or years?

A: Treatment with Basol is generally limited to two consecutive weeks because prolonged application significantly increases the risk of serious systemic adverse effects. These include skin thinning (atrophy), HPA axis suppression, and potential signs of Cushing’s syndrome.


Q: Is there a generic equivalent to the Basol Solution formulation?

A: The active ingredient in Basol, Clobetasol propionate, is available as a generic medication. It is produced by various manufacturers in several different approved formulations.


Q: Why might a doctor prescribe Basol instead of a less potent corticosteroid cream for a skin condition?

A: Basol is classified as a super-high potency topical corticosteroid. It is typically prescribed for treating the most severe and highly inflamed or itchy skin conditions where a less potent steroid may be insufficient.


Q: What are the active ingredients in Basol and what is the role of each component?

A: The active ingredient in Basol is Clobetasol propionate, which is responsible for the anti-inflammatory effect. All other components are considered inactive ingredients and form the base (like the cream or solution), which is necessary to deliver the active drug to the skin.


Q: Is it normal to feel a slight tingling or burning sensation when first applying Basol?

A: Both a burning and stinging sensation are listed in regulatory information among the most common adverse reactions reported at the application site.


Q: Can Basol interact with common over-the-counter pain relievers or supplements?

A: The official label names specific prescription drugs that interact, but does not explicitly list common over-the-counter pain relievers or supplements. Patients are advised in prescribing information to communicate all medications and supplements being taken to their healthcare provider.


Q: Does Basol interact negatively with other topical creams or skincare products?

A: The official label does not specify direct negative topical interactions. However, using more than one product containing a corticosteroid simultaneously may increase the total amount of steroid absorbed into the body.


Q: Does Basol have any effect on blood pressure or heart rate, as an electrolyte-containing product?

A: Systemic absorption can lead to side effects like high blood sugar and an increased risk of low potassium, which are conditions that can indirectly affect the cardiovascular system. Patients with pre-existing heart conditions were generally excluded from clinical trials.


Q: Are there any specific activities, like swimming or sun exposure, to avoid while using Basol?

A: The drug must be protected from light during storage. While the label does not explicitly restrict sun exposure during treatment, patients are often advised to protect treated areas from excessive sun. Additionally, some formulations are flammable and require caution.


Q: The typical texture or consistency of Basol solution?

A: Basol is available in multiple forms including a cream, ointment, gel, and solution. The solution form is a liquid dosage preparation designed for application, often used for hairy areas like the scalp.


Q: Does Basol contain any common allergens, such as parabens or lanolin?

A: Basol is contraindicated for patients with a known allergy to the active ingredient or any component of the formulation. Manufacturers are required to list all ingredients, including excipients that may be common allergens, on the full prescribing label.

How should Basol be stored and disposed of?

How to Store and Dispose of Basol (Clobetasol Propionate)

Official regulatory documents define strict conditions for the storage and disposal of Basol.

Storage Requirements

Item Requirement Statement
Temperature Store at Controlled Room Temperature, typically 15 °C to 30 °C (59 °F to 86 °F). Do not refrigerate (for most formulations).
Protection Keep container tightly closed and protect the product from light and moisture.
Child Safety Keep this and all medication out of the reach of children. The product should be stored locked up.

Disposal Instructions

Unused or expired medication must not be emptied into drains or wastewater to prevent release to the environment. Basol must be disposed of at an appropriate treatment and disposal facility in accordance with local pharmaceutical waste regulations. Consult local authorities for specific collection programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Basol found in:

A-Z Index: